| AASLD

Erratum for Cannata Serio et al. Mutations in the V‐ATPase assembly factor VMA21 cause a congenital disorder of glycosylation with autophagic liver disease

Read more about Erratum for Cannata Serio et al. Mutations in the V‐ATPase assembly factor VMA21 cause a congenital disorder of glycosylation with autophagic liver disease

20 January 2022

Features of Cirrhotic Cardiomyopathy Early in the Lives of Infants With Biliary Atresia Correlate With Outcomes Following Kasai Portoenterostomy

Read more about Features of Cirrhotic Cardiomyopathy Early in the Lives of Infants With Biliary Atresia Correlate With Outcomes Following Kasai Portoenterostomy

Jhavene Morrison, Eric Ferguson, Janet Figueroa, Saul J. Karpen – 20 January 2022 – Cirrhotic cardiomyopathy (CCM), detected during two‐dimensional echocardiography (2DE), is prevalent in patients with biliary atresia (BA) awaiting transplant. Whether CCM occurs early in the lives of infants with BA is unknown. The aim of this study was to explore the incidence and consequence of CCM in patients with BA, focusing on the earliest ages when 2DE was performed. A cohort of 78 patients with BA at a single center underwent 2DE (median age = 132 days) during the first year of life.

Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes

Read more about Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes

Dandan Mao, Eric S.H. Lau, Hongjiang Wu, Aimin Yang, Baoqi Fan, Mai Shi, Claudia H.T. Tam, Elaine Chow, Alice P.S. Kong, Ronald C.W. Ma, Andrea Luk, Juliana C.N. Chan – 18 January 2022 – Liver is a major site for glucose metabolism. Patients with type 2 diabetes (T2D) and obesity have increased risk of liver cancer. We explored the association of glycemic burden (GB) and obesity with liver cancer in T2D in the prospective Hong Kong Diabetes Register (1995‐2019).

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Read more about Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Yuan Fang, Weiren Liu, Zheng Tang, Xiang Ji, Yufu Zhou, Shushu Song, Mengxin Tian, Chenyang Tao, Run Huang, Guiqi Zhu, Xifei Jiang, Jun Gao, Weifeng Qu, Han Wang, Peiyun Zhou, Xiaoling Wu, Lei Jin, Haixiang Sun, Zhenbin Ding, Yuanfei Peng, Shimin Zhao, Jian Zhou, Jia Fan, Wei Xu, Yinghong Shi – 18 January 2022

Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India

Read more about Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India

Anand V. Kulkarni, Pavan Hanchanale, Vikash Prakash, Chetan Kalal, Mithun Sharma, Karan Kumar, Saptarshi Bishnu, Aditya V. Kulkarni, Lovkesh Anand, Ajay Kumar Patwa, Sandeep Kumbar, Sumeet Kainth, Cyriac Abby Philips, for the Liver Research Club India – 16 January 2022 – Tinospora cordifolia (Giloy) is an herbal supplement commonly used in the Indian alternative medicine system Ayurveda. This herb has been promoted to the public in India as an immune booster to prevent novel coronavirus disease 2019.